Abstract
Chronic pancreatitis is an inflammatory disorder of the pancreas. We analyzed CPA1, encoding carboxypeptidase A1, in subjects with nonalcoholic chronic pancreatitis (cases) and controls in a German discovery set and three replication sets. unctionally impaired variants were present in 29/944 (3.1%) German cases and 5/3,938 (0.1%) controls (odds ratio (OR) = 24.9, P = 1.5 X 10-16). The association was strongest in subjects aged =10 years (9.7%; OR = 84.0, P = 4.1 X 10-24). In the replication sets, defective CPA1 variants were present in 8/600 (1.3%) cases and 9/2,432 (0.4%) controls from Europe (P = 0.01), 5/230 (2.2%) cases and 0/264 controls from India (P = 0.02) and 5/247 (2.0%) cases and 0/341 controls from Japan (P = 0.013). The mechanism by which CPA1 variants confer increased pancreatitis risk may involve misfolding-induced endoplasmic reticulum stress rather than elevated trypsin activity, as is seen with other genetic risk factors for this disease.
Original language | English |
---|---|
Pages (from-to) | 1216-1220 |
Number of pages | 5 |
Journal | Nature Genetics |
Volume | 45 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2013 |
Fingerprint
Dive into the research topics of 'Variants in CPA1 are strongly associated with early onset chronic pancreatitis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Nature Genetics, Vol. 45, No. 10, 10.2013, p. 1216-1220.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Variants in CPA1 are strongly associated with early onset chronic pancreatitis
AU - Witt, Heiko
AU - Beer, Sebastian
AU - Rosendahl, Jonas
AU - Chen, Jian Min
AU - Chandak, Giriraj Ratan
AU - Masamune, Atsushi
AU - Bence, Melinda
AU - Szmola, Richárd
AU - Oracz, Grzegorz
AU - Macek, Milan
AU - Bhatia, Eesh
AU - Steigenberger, Sandra
AU - Lasher, Denise
AU - Bühler, Florence
AU - Delaporte, Catherine
AU - Tebbing, Johanna
AU - Ludwig, Maren
AU - Pilsak, Claudia
AU - Saum, Karolin
AU - Bugert, Peter
AU - Masson, Emmanuelle
AU - Paliwal, Sumit
AU - Bhaskar, Seema
AU - Sobczynska-Tomaszewska, Agnieszka
AU - Bak, Daniel
AU - Balascak, Ivan
AU - Choudhuri, Gourdas
AU - Reddy, D. Nageshwar
AU - Rao, G. Venkat
AU - Thomas, Varghese
AU - Kume, Kiyoshi
AU - Nakano, Eriko
AU - Kakuta, Yoichi
AU - Shimosegawa, Tooru
AU - Durko, Lukasz
AU - Szabó, András
AU - Schnúr, Andrea
AU - Hegyi, Péter
AU - Rakonczay, Zoltán
AU - Pfützer, Roland
AU - Schneider, Alexander
AU - Groneberg, David Alexander
AU - Braun, Markus
AU - Schmidt, Hartmut
AU - Witt, Ulrike
AU - Friess, Helmut
AU - Algül, Hana
AU - Landt, Olfert
AU - Schuelke, Markus
AU - Krüger, Renate
AU - Wiedenmann, Bertram
AU - Schmidt, Frank
AU - Zimmer, Klaus Peter
AU - Kovacs, Peter
AU - Stumvoll, Michael
AU - Blüher, Matthias
AU - Müller, Thomas
AU - Janecke, Andreas
AU - Teich, Niels
AU - Grützmann, Robert
AU - Schulz, Hans Ulrich
AU - Mössner, Joachim
AU - Keim, Volker
AU - Löhr, Matthias
AU - Férec, Claude
AU - Sahin-Tóth, Miklós
N1 - Funding Information: The authors thank all study participants and the members of the Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) for providing clinical data and blood samples. The authors also thank C. Ruffert (Leipzig), K. Krohn, K. Schön and B. Oelzner (Interdisziplinäres Zentrum für Klinische Forschung (IZKF) core unit DNA technologies, Leipzig), V. Sahin-Tóth (Boston) and K.R. Mani (CCMB, Hyderabad) for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grants Wi 2036/2-2 and Wi 2036/2-3 (to H.W.) and RO 3929/1-1 and RO 3939/2-1 (to J.R.), the Else Kröner-Fresenius-Foundation (EKFS) (to H.W.), a grant of the Colora Stiftung gGmbH (to J.R.), US National Institutes of Health (NIH) grants R01DK058088, R01DK082412, R01DK082412-S2 and R01DK095753 (to M.S.-T.), fellowships from the Rosztoczy Foundation (to M. Bence and A. Schnúr), the Bolyai postdoctoral fellowship from the Hungarian Academy of Sciences (to R.S.), INSERM, the Programme Hospitalier de Recherche Clinique (PHRC R 08-04), the French Association des Pancréatites Chroniques Héréditaires and its president N. Meslet, the Czech Ministry of Health conceptual development project of research organization University Hospital Motol in Prague (00064203) and grants CZ.2.16/3.1.00/24022OPPK (to M.M.), the Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Government of India, India grant GENESIS (to G.R.C.), a Grant-in-Aid from the Japan Society for the Promotion of Science (#23591008 to A.M.) and the Research Committee of Intractable Pancreatic Diseases provided by the Ministry of Health, Labour and Welfare of Japan (to A.M. and T.S.). Funding Information: 1Else Kröner-Fresenius-Zentrum für Ernährungsmedizin (EKFZ), Technische Universität München (TUM), Freising, Germany. 2Zentralinstitut für Ernährungs-und Lebensmittelforschung (ZIEL), TUM, Freising, Germany. 3Department of Pediatrics, Klinikum Rechts der Isar (MRI), TUM, Munich, Germany. 4Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, Massachusetts, USA. 5Department for Internal Medicine, Neurology and Dermatology, Division of Gastroenterology, University of Leipzig, Leipzig, Germany. 6Institut National de la Santé et de la Recherche Médicale (INSERM), U1078, Etablissement Français du Sang (EFS)–Bretagne, Brest, France. 7Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France. 8Centre for Cellular and Molecular Biology (CCMB), Council of Scientific and Industrial Research (CSIR), Hyderabad, India. 9Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. 102nd Department of Medicine, Semmelweis University, Budapest, Hungary. 11Department of Gastroenterology, Hepatology and Immunology, The Children’s Memorial Health Institute, Warsaw, Poland. 12Department of Biology and Medical Genetics, University Hospital Motol and 2nd Faculty of Medicine of Charles University Prague, Prague, Czech Republic. 13Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. 14Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. 15MedGen Health Care Centre, Warsaw, Poland. 16Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland. 17Clinic of Obstetrics and Gynecology, Department of Neonatology, University Hospital Motol and 2nd Medical School, Charles University Prague, Prague, Czech Republic. 18Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. 19Asian Institute of Gastroenterology, Hyderabad, India. 20Department of Gastroenterology, Medical College Hospital, Calicut, India. 21Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland. 221st Department of Medicine, University of Szeged, Szeged, Hungary. 23Department of Internal Medicine, Klinikum Döbeln, Döbeln, Germany. 24Department of Medicine II, Universitätsmedizin Mannheim, Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany. 25Institute for Occupational Medicine, Goethe-Universität Frankfurt, Frankfurt, Germany. 26Department for Transplant Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany. 27Department of Surgery, TUM, Munich, Germany. 28Department of Gastroenterology, TUM, Munich, Germany. 29TIB MOLBIOL, Berlin, Germany. 30Department of Neuropediatrics, Charité, Campus Virchow-Klinikum, Berlin, Germany. 31NeuroCure Clinical Research Center, Charité, Campus Virchow-Klinikum, Berlin, Germany. 32Department of Pediatrics, Division of Pediatric Pulmonology, Charité, Campus Virchow-Klinikum, Berlin, Germany. 33Department of Internal Medicine, Division of Hepatology and Gastroenterology, Charité, Campus Virchow-Klinikum, Berlin, Germany. 34Department of Pediatrics, University of Halle-Wittenberg, Halle (Saale), Germany. 35Department of Pediatrics, Justus-Liebig-Universität, Gießen, Germany. 36Department for Internal Medicine, Neurology and Dermatology, Division of Endocrinology, University of Leipzig, Leipzig, Germany. 37Integriertes Forschungs-und Behandlungszentrum (IFB) Adiposity Diseases, University of Leipzig, Leipzig, Germany. 38Universitätsklinik für Pädiatrie I, Department für Kinder-und Jugendheilkunde, Medizinische Universität Innsbruck, Innsbruck, Austria. 39Sektion für Humangenetik, Medizinische Universität Innsbruck, Innsbruck, Austria. 40Practice for Digestive and Metabolic Diseases, Leipzig, Germany. 41Department of Surgery, Universitätsklinikum Dresden, Dresden, Germany. 42Department of Surgery, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. 43Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. 44These authors contributed equally to this work. Correspondence should be addressed to H.W. ([email protected]) or M.S.-T. ([email protected]).
PY - 2013/10
Y1 - 2013/10
N2 - Chronic pancreatitis is an inflammatory disorder of the pancreas. We analyzed CPA1, encoding carboxypeptidase A1, in subjects with nonalcoholic chronic pancreatitis (cases) and controls in a German discovery set and three replication sets. unctionally impaired variants were present in 29/944 (3.1%) German cases and 5/3,938 (0.1%) controls (odds ratio (OR) = 24.9, P = 1.5 X 10-16). The association was strongest in subjects aged =10 years (9.7%; OR = 84.0, P = 4.1 X 10-24). In the replication sets, defective CPA1 variants were present in 8/600 (1.3%) cases and 9/2,432 (0.4%) controls from Europe (P = 0.01), 5/230 (2.2%) cases and 0/264 controls from India (P = 0.02) and 5/247 (2.0%) cases and 0/341 controls from Japan (P = 0.013). The mechanism by which CPA1 variants confer increased pancreatitis risk may involve misfolding-induced endoplasmic reticulum stress rather than elevated trypsin activity, as is seen with other genetic risk factors for this disease.
AB - Chronic pancreatitis is an inflammatory disorder of the pancreas. We analyzed CPA1, encoding carboxypeptidase A1, in subjects with nonalcoholic chronic pancreatitis (cases) and controls in a German discovery set and three replication sets. unctionally impaired variants were present in 29/944 (3.1%) German cases and 5/3,938 (0.1%) controls (odds ratio (OR) = 24.9, P = 1.5 X 10-16). The association was strongest in subjects aged =10 years (9.7%; OR = 84.0, P = 4.1 X 10-24). In the replication sets, defective CPA1 variants were present in 8/600 (1.3%) cases and 9/2,432 (0.4%) controls from Europe (P = 0.01), 5/230 (2.2%) cases and 0/264 controls from India (P = 0.02) and 5/247 (2.0%) cases and 0/341 controls from Japan (P = 0.013). The mechanism by which CPA1 variants confer increased pancreatitis risk may involve misfolding-induced endoplasmic reticulum stress rather than elevated trypsin activity, as is seen with other genetic risk factors for this disease.
UR - http://www.scopus.com/inward/record.url?scp=84885019350&partnerID=8YFLogxK
U2 - 10.1038/ng.2730
DO - 10.1038/ng.2730
M3 - Article
C2 - 23955596
AN - SCOPUS:84885019350
SN - 1061-4036
VL - 45
SP - 1216
EP - 1220
JO - Nature Genetics
JF - Nature Genetics
IS - 10
ER -